Which ante mortem clinical features predict progressive supranuclear palsy pathology?-Reference-Cited by-同舟云学术

Which ante mortem clinical features predict progressive supranuclear palsy pathology?

Published:2017-05-13 Issue:7 Volume:32 Page:995-1005
ISSN:0885-3185
Container-title:Movement Disorders
language:en
Short-container-title:Mov Disord.

Author:

Respondek Gesine¹²,Kurz Carolin³,Arzberger Thomas²³⁴,Compta Yaroslau⁵,Englund Elisabet⁶,Ferguson Leslie W.⁷,Gelpi Ellen⁸,Giese Armin⁴,Irwin David J.⁹,Meissner Wassilios G.¹⁰¹¹¹²^ORCID,Nilsson Christer¹³,Pantelyat Alexander¹⁴,Rajput Alex⁷,van Swieten John C.¹⁵,Troakes Claire¹⁶,Josephs Keith A.¹⁷,Lang Anthony E.¹⁸,Mollenhauer Brit¹⁹,Müller Ulrich²⁰,Whitwell Jennifer L.²¹,Antonini Angelo²²,Bhatia Kailash P.²³^ORCID,Bordelon Yvette²⁴,Corvol Jean-Christophe²⁵,Colosimo Carlo²⁶,Dodel Richard²⁷,Grossman Murray⁹,Kassubek Jan²⁸,Krismer Florian²⁹,Levin Johannes³⁰,Lorenzl Stefan³¹³²³³,Morris Huw³⁴,Nestor Peter³⁵,Oertel Wolfgang H.³⁶,Rabinovici Gil D.³⁷,Rowe James B.³⁸,van Eimeren Thilo³⁹,Wenning Gregor K.²⁹,Boxer Adam³⁷,Golbe Lawrence I.⁴⁰,Litvan Irene⁴¹,Stamelou Maria³⁶⁴²⁴³^ORCID,Höglinger Günter U.¹²^ORCID,

Affiliation:

1. Department of Neurology; Technische Universität München; Munich Germany

2. German Center for Neurodegenerative Diseases; Munich Germany

3. Department of Psychiatry; Ludwig-Maximilians-Universität; Munich Germany

4. Center for Neuropathology and Prion Research; Ludwig-Maximilians-University; Munich Germany

5. Parkinson's Disease & Movement Disorders Unit, Neurology Service; Hospital Clinic/IDIBAPS/University of Barcelona/CIBERNED; Barcelona Catalonia Spain

6. Department of Clinical Sciences, Division of Oncology and Pathology; Lund University; Lund Sweden

7. Division of Neurology, Royal University Hospital; University of Saskatchewan; Saskatchewan Canada

8. Neurological Tissue Bank and Neurology Department, Hospital Clínic de Barcelona; Universitat de Barcelona; IDIBAPS, CERCA Barcelona Catalonia Spain

9. Frontotemporal Degeneration Center, Department of Neurology; University of Pennsylvania; Pennsylvania USA

10. University of Bordeaux, Institut des Maladies Neurodégénératives; UMR 5293 Bordeaux France

11. Centre national de la recherche scientifique (CNRS), Institut des Maladies Neurodégénératives; UMR 5293 Bordeaux France

12. Service de Neurologie, Hôpital Pellegrin; CHU de Bordeaux; Bordeaux France

13. Department of Clinical Sciences, Division of Neurology; Lund University; Lund Sweden

14. Department of Neurology; Johns Hopkins University; Baltimore Maryland USA

15. Department of Neurology; Erasmus Medical Centre; Rotterdam The Netherlands

16. London Neurodegenerative Diseases Brain Bank, Institute of Psychiatry, Psychology and Neuroscience; Kings College London; UK

17. Department of Neurology; Mayo Clinic; Rochester Minnesota USA

18. Morton and Gloria Shulman Movement Disorders Clinic and the Edmond J Safra Program in Parkinson's Disease; Toronto Western Hospital; Toronto Canada

19. Paracelsus-Elena Klinik Kassel and University Medical Center Goettingen, Institute of Neuropathology; Goettingen Germany

20. Institute of Human Genetics; Giessen Germany

21. Department of Radiology; Mayo Clinic; Rochester Minnesota USA

22. Parkinson and Movement Disorders Unit, Istituto di ricovero e cura a carattere scientifico (IRCCS) Hospital San Camillo and Department of Neurosciences (DNS); Padova University; Padova Italy

23. Sobell Department of Motor Neuroscience and Movement Disorders; UCL Institute of Neurology; London UK

24. Department of Neurology; University of California; Los Angeles California USA

25. Sorbonne Universités, Université Pierre et Marie Curie (UPMC Univ) Paris 06; and INSERM UMRS_1127, CIC_1422; and CNRS UMR_7225; and Assistance publique - Hôpitaux de Paris (AP-HP); and Institut du Cerveau et de la Moelle Epinière (ICM), Hôpital Pitié-Salpêtrière, Département des maladies du système nerveux; F-75013 Paris France

26. Department of Neurology; Santa Maria University Hospital of Terni; Terni Italy

27. Department of Geriatric Medicine; University Hospital Essen; Essen Germany

28. Department of Neurology; University of Ulm; Ulm Germany

29. Department of Neurology; Medical University Innsbruck; Innsbruck Austria

30. Department of Neurology; Ludwig-Maximilians-Universität; Munich Germany

31. Department of Palliative Medicine; Munich University Hospital, Ludwig-Maximilians-Universität (LMU), Munich; Munich Germany

32. Institute of Nursing Science and Practice; Paracelsus Medical University; Salzburg Austria

33. Department of Neurology; Hospital Agatharied; Agatharied Germany

34. Department of Clinical Neuroscience; UCL Institute of Neurology; London UK

35. German Center for Neurodegenerative Diseases; Magdeburg Germany

36. Department of Neurology; Philipps Universität; Marburg Germany

37. Memory and Aging Center, Department of Neurology; University of California; San Francisco California USA

38. Department of Clinical Neurosciences; Cambridge University; Cambridge UK

39. Department of Nuclear Medicine; University Hospital Cologne; Cologne Germany

40. Department of Neurology; Rutgers Robert Wood Johnson Medical School; New Brunswick New Jersey USA

41. Department of Neurology; University of California; San Diego California USA

42. Second Department of Neurology, Attikon University Hospital; University of Athens; Greece

43. HYGEIA Hospital; Athens Greece

Funder

Bischof Dr. Karl Golser Stiftung

CurePSP

Deutsche Forschungsgemeinschaft

German Center for Neurodegenerative Diseases e.V. (DZNE)

German PSP Gesellschaft

Tau Consortium

UK PSP Association

International Parkinson & Movement Disorder Society

Publisher

Wiley

Subject

Clinical Neurology,Neurology

Reference78 articles.

1. Progressive supranuclear palsy. A heterogeneous degeneration involving the brain stem, basal ganglia and cerebellum with vertical gaze and pseudobulbar palsy, nuchal dystonia and dementia;Steele;Arch Neurol,1964

2. Prevalence, characteristics, and survival of frontotemporal lobar degeneration syndromes;Coyle-Gilchrist;Neurology,2016

3. Prevalence of progressive supranuclear palsy and multiple system atrophy: a cross-sectional study;Schrag;Lancet,1999

4. The phenotypic spectrum of progressive supranuclear palsy: a retrospective multicenter study of 100 definite cases;Respondek;Mov Disord,2014

5. Neuropathologic differentiation of progressive supranuclear palsy and corticobasal degeneration;Dickson;J Neurol,1999

Cited by 130 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Correlation between clinical and neuropathological subtypes of PSP: Do clinical symptoms reflect tau distribution?;Parkinsonism & Related Disorders;2024-09

2. Alzheimer’s Disease-Related Cerebrospinal Fluid Biomarkers in Progressive Supranuclear Palsy;Brain Sciences;2024-08-26

3. Progressive supranuclear palsy: Neuropathology, clinical presentation, diagnostic challenges, management, and emerging therapies;Disease-a-Month;2024-08

4. Progressive Supranuclear Palsy Diagnosed After a Severe Fall Trauma in a Patient Who Experienced Episodes of Easy Falling;Cureus;2024-05-04

5. Differential Synaptic Loss in β‐Amyloid Positive Versus β‐Amyloid Negative Corticobasal Syndrome;Movement Disorders;2024-04-26